Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR–ABL1-positive acute lymphoblastic leukemia patients.

MLA

Iacobucci, I., et al. “Different Isoforms of the B-Cell Mutator Activation-Induced Cytidine Deaminase Are Aberrantly Expressed in BCR–ABL1-Positive Acute Lymphoblastic Leukemia Patients.” Leukemia (08876924), vol. 24, no. 1, Jan. 2010, pp. 66–73. EBSCOhost, https://doi.org/10.1038/leu.2009.197.

APA

Iacobucci, I., Lonetti, A., Messa, F., Ferrari, A., Cilloni, D., Soverini, S., Paoloni, F., Arruga, F., Ottaviani, E., Chiaretti, S., Messina, M., Vignetti, M., Papayannidis, C., Vitale, A., Pane, F., Piccaluga, P. P., Paolini, S., Berton, G., Baruzzi, A., & Saglio, G. (2010). Different isoforms of the B-cell mutator activation-induced cytidine deaminase are aberrantly expressed in BCR–ABL1-positive acute lymphoblastic leukemia patients. Leukemia (08876924), 24(1), 66–73. https://doi.org/10.1038/leu.2009.197

Chicago

Iacobucci, I., A. Lonetti, F. Messa, A. Ferrari, D. Cilloni, S. Soverini, F. Paoloni, et al. 2010. “Different Isoforms of the B-Cell Mutator Activation-Induced Cytidine Deaminase Are Aberrantly Expressed in BCR–ABL1-Positive Acute Lymphoblastic Leukemia Patients.” Leukemia (08876924) 24 (1): 66–73. doi:10.1038/leu.2009.197.